These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1476395)

  • 1. Markers of vascular injury in Behçet's disease associated with retinal vasculitis.
    Pivetti-Pezzi P; Priori R; Catarinelli G; Meroni PL; Federici AB; Abdulaziz M; Falco M; Valesini G
    Ann Ophthalmol; 1992 Nov; 24(11):411-4. PubMed ID: 1476395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticardiolipin antibodies and retinal vascular complications in Behçet's disease.
    Ozdemir Y; Onder F; Yarangümeli A; Küçükkuyumcu C; Kural G
    Ophthalmic Surg Lasers; 1997 Aug; 28(8):653-6. PubMed ID: 9268996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-endothelial cell antibodies in retinal vasculitis.
    Edelsten C; D'Cruz D; Hughes GR; Graham EM
    Curr Eye Res; 1992; 11 Suppl():203-8. PubMed ID: 1424746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticardiolipin antibodies in uveitis.
    Klok AM; Geertzen R; Rothova A; Baarsma GS; Kijlstra A
    Curr Eye Res; 1992; 11 Suppl():209-13. PubMed ID: 1424747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinal vasculitis in Behçet's disease].
    Ermakova NA; Alekberova ZS
    Vestn Oftalmol; 2001; 117(1):44-6. PubMed ID: 11339043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to endothelial cells in patients with Behçet's disease.
    Aydìntug AO; Tokgöz G; D'Cruz DP; Gürler A; Cervera R; Düzgün N; Atmaca LS; Khamashta MA; Hughes GR
    Clin Immunol Immunopathol; 1993 May; 67(2):157-62. PubMed ID: 8519091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of antiendothelial cell antibodies in Behcet's disease].
    Zheng WJ; Zhao Y; Tang FL; Dong Y
    Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):910-3. PubMed ID: 16409728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine level and uveitis in Behçet's disease.
    Okka M; Oztürk M; Kockar MC; Bavbek N; Rasier Y; Gunduz K
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):931-4. PubMed ID: 12455183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological investigations in retinal vasculitis.
    Graham E; Spalton DJ; Sanders MD
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):12-6. PubMed ID: 6964217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K; Fijnheer R; Rothova A
    Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-endothelial cell antibodies in systemic vasculitis: detection and correlation with disease activity].
    Zeng XJ; Zhu WG; Deng XX; Tang FL; Dong Y
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1629-32. PubMed ID: 15569459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinal thrombosis in young patients. Immunological and clinical aspects].
    Cobo Soriano R; Aparicio Hernández-Lastras MJ; Seoane E; Sánchez-Ramón S; Vidal Fernández P; Teijeiro Permuy MA; Carboné J; Suárez Leoz M
    Arch Soc Esp Oftalmol; 2001 Mar; 76(3):181-8. PubMed ID: 11283785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of the distribution of major histocompatibility system antigens in retinal vasculitis in patients with Behçet's disease].
    Ermakova NA
    Vestn Oftalmol; 2003; 119(1):31-3. PubMed ID: 12608042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease.
    Leiba M; Seligsohn U; Sidi Y; Harats D; Sela BA; Griffin JH; Livneh A; Rosenberg N; Gelernter I; Gur H; Ehrenfeld M
    Ann Rheum Dis; 2004 Nov; 63(11):1445-9. PubMed ID: 15479893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance.
    Navarro M; Cervera R; Font J; Reverter JC; Monteagudo J; Escolar G; López-Soto A; Ordinas A; Ingelmo M
    Lupus; 1997; 6(6):521-6. PubMed ID: 9256310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behçet's disease sera containing antiendothelial cell antibodies promote adhesion of T lymphocytes to cultured human dermal microvascular endothelial cells.
    Lee KH; Chung HS; Bang D; Lee S
    Yonsei Med J; 1999 Apr; 40(2):152-8. PubMed ID: 10333719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin antibodies in Adamantiades-Behçet's disease.
    Zouboulis CC; Büttner P; Tebbe B; Orfanos CE
    Br J Dermatol; 1993 Mar; 128(3):281-4. PubMed ID: 8471511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.